The scientific base of the company is centered in RIKEN’s omics center, Yokohama, around Piero Carninci’s team, in collaboration with the International School of Advanced Studies, Trieste.
Nikkei Biotech, Oct. 31, 2012
RIKEN forms 34th venture company “TransSine Technologies”, technology base is promotion of protein synthesis by non-coding RNA